To investigate whether SREBP1 expression relates to chemosensitivity in CRC patients, we first compared the expression levels of SREBP1 in CRC colonoscopy samples from 21 rectal cancer patients who subsequently underwent neoadjuvant chemotherapy. This evidence concerns the gene SREBF1 and colorectal carcinoma.